THE USE OF IMMUNOMODULATORS TO PREVENT RESPIRATORY INFECTIONS IN CHILDREN WITH ALLERGIC DISEASES

Background: Children with allergic diseases, especially bronchial asthma, are in need of protection from acute respiratory infections, as anti-epidemic  measures cannot prevent the spread of influenza; vaccination remains the best means of prevention. Another promising direction in the prevention of acute respiratory infections (ARI) can be immunomodulators of bacterial origin. Objective:  Our aim was to study the use of immunomodulators for prevention of respiratory infections with children having allergic diseases.

Methods. A comparative analysis of prophylactic efficiency of specific and nonspecific immunoprophylaxis of ARI with children having allergic diseases has been done during three epedemic seasons (2011–2014).

Results.  For immunization of 335 children aged 3–17 years having a variety of allergic diseases, vaccine (domestic and foreign) in combination with an immunomodulator, and without it have been used. With the help of vaccination, the number of cases of ARI during the whole observation period decreased significantly: 21 (6.3%) children did not have ARI,62 (18.5%) children had ARI once, 252 (75.2%) children — from 1–4 times in a year. Also, significant reduction of frequency of aggravation of the basic disease was observed in all treatment groups. Patients who received only immunomodulator, had significant reduction of both ARI and the basic disease (p <0,05).

Conclusion. The use of vaccines in combination with an immunomodulator or without it fully protects children from flu and significantly (1.5 times) reduces prevalence of ARI.

1. Коровина Н.А., Заплатников А.Л., Леписева И.В. и др. Современные возможности иммунопрофилактики острых респираторных инфекций у часто болеющих детей // Педиатрическая фармакология. — 2008. — Т. 5. — № 1 — С. 21–25. [Korovina NA, Zaplatnikov AL, Lepiseva IV, et al. Modern capabilities of immunoprophylaxis of acute respiratory infections in frequently ailing children. Pediatric pharmacology. 2008;5(1):21–25. (In Russ).]

2. Намазова-Баранова Л.С. Аллегия у детей: от теории — к практике. Серия: Современная педиатрия: от теории — к практике. — М.: ПедиатрЪ; 2011. — С. 166–175. [Namazova-Baranova LS. Allegiya u detei: ot teorii — k praktike. Series: Sovremennaya pediatriya: ot teorii — k praktike. Moscоw: Pediatr»»; 2011. p. 166–175. (In Russ).]

3. Альбицкий В.Ю, Баранов А.А., Камаев И.А., Огнева М.Л. Часто болеющие дети. — Н. Новгород: НГМА; 2003. — 180 с. [Al’bitskii VYu, Baranov AA, Kamaev IA, Ogneva ML. Chasto boleyushchie deti. Nizhnii novgorod: NGMA; 2003. 180 p. (In Russ).]

4. Костинов М.П., Гурвич Э.Б. Вакцины нового поколения в профилактике инфекционных заболеваний. — М.: Медицина для всех; 2002. — 152 с. [Kostinov MP, Gurvich EB. Vaktsiny novogo pokoleniya v profilaktike infektsionnykh zabolevanii. Moscow: Meditsina dlya vsekh; 2002. 152 p. (In Russ).]

5. Борисова В.Н., Булгакова В.А., Ванеева Н.П. и др. Иммуномодуляторы и вакцинация / Под ред. Костинова М.П., Соловьевой И.Л. — М.: М-пресс; 2013. — 272 с. [Borisova VN, Bulgakova VA, Vaneeva NP, et al. Immunomodulyatory i vaktsinatsiya. Ed by Kostinov M.P., Solov’eva I.L. Moscow: M-press; 2013. 272 p. (In Russ).]

6. Онищенко Г.Г. Состояние вакцинопрофилактики в России и перспективы ее развития. — М.: Российские медицинские вести МЗ РФ; 2008. С. 4. [Onishchenko GG. Sostoyanie vaktsinoprofilaktiki v Rossii i perspektivy ee razvitiya. Moscow: Rossiiskie meditsinskie vesti MZ RF; 2008. p. 4. (In Russ).]

7. ВОЗ. Рекомендации по использованию инактивированных противогриппозных вакцин и других профилактических мер. Wkly Epidemiol Rec. 2012;75:281–288.

8. Учайкин В.Ф., Шамшева О.В. Инфекционные болезни у детей. — М.; 2015. — С. 71–112. [Uchaikin VF, Shamsheva OV. Infektsionnye bolezni u detei. Moscow; 2015. p. 71–112. (In Russ).]

9. Харит С.М. Вакцинация: современные возможности снижения заболеваемости // Фарматека. — 2014. — № 3 — С. 8–13. [Kharit SM. Vaktsinatsiya: sovremennye vozmozhnosti snizheniya zabolevaemosti. Farmateka. 2014;(3):8–13. (In Russ).]

10. Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis — a prospective follow-up to 7 years of age. Allergy. 2000;55(3): 240–245. doi: 10.1034/j.1398-9995.2000.00391.x.

11. Маянский А.Н. Вирус гриппа А: строение, экология, патология // Вопросы диагностики в педиатрии. — 2009. — Т. 1. — № 6 — С. 8–17. [Mayanskiy AN. Influenza virus A: structure, ecology, pathology. Pediatric diagnostics. 2009;1(6):8–17. (In Russ).]

12. eswi.org [Internet]. Europian Scientific Working group on Influenzae [cited 2016 Dec 9]. Available from: http://eswi.org/knowledge-center/.

13. Караулов А.В. Полиоксидоний в клинической практике. — М.: ГЭОТАР-Медиа; 2008. — 136 с. [Karaulov AV. Polioksidonii v klinicheskoi praktike. Moscow: GEOTAR-Media. 2008. p. 136. (In Russ).]

14. Баранов А.А., Хаитов Р.М. Аллергология и иммунология. Клинические рекомендации для педиатров. — М.: Союз педиатров России; 2011. — 33 с. [Baranov AA, Khaitov RM. Allergologiya i immunologiya. Klinicheskie rekomendatsii dlya pediatrov. Moscow: Soyuz pediatrov Rossii. 2011. p. 33. (In Russ).]

15. Зверев В.В., Хаитов Р.М. Вакцины и вакцинация. Национальное руководство. — М.; 2014. — 110 с. [Zverev VV, Khaitov RM. Vaktsiny i vaktsinatsiya. Natsional’noe rukovodstvo. Moscow; 2014. p. 110. (In Russ).]

16. Margolis KL, Nichol KL, Poland GA, Pluhar RE. Frequency of adverse reactions to influenza vaccine in the elderly. A randomized, placebo-controlled trial. JAMA. 1990;264(9):1139–1141. doi: 10.1001/jama.1990.03450090075029.

17. Glezen WP. Consideration of the risk of influenza in children and indications for prophylaxis. Rev Inf Dis. 1980;2(3):408–420.